Search & Analyze

Entero Healthcare Solutions Ltd.

1,573.75+14.45 (+0.93%)

BSE · 30 Oct, 4:01 PM

: ₹6,856.67 Cr
: 54.68
: 3,316
: ₹1,577.00 - ₹1,535.00
: ₹1,919.25 - ₹944.00

Entero Healthcare Solutions Ltd. (ENTERO) share price closed at ₹1,573.75 on the BSE on Friday, October 30, 2026, up by 0.93% from its of ₹1,559.30. In that session ENTERO reached a of 1,577.00 and of 1,535.00. The for the session was 1,563.39. The stands at 1,682.89 and is at 1,307.88. Looking at , the stock ended the session in Uptrend.

Stock Overview

₹1,548.55

₹1,559.30

₹1,563.39

₹1,682.89

Price 6.49% below

₹1,307.88

Price 20.33% above

Key Fundamentals

: 6,856.67 Cr₹6.86 Thousand Crore
: 28.78
: 54.68
: 3.95
: 398.17
: 329.29 Cr₹329.29 Crore
: 0.00 %
Sector
Industry: Trading
: 8.57
: 0.34

Industry Comparison

Ratio	Company	Sector
	54.68	17.35
	0.34	0.20
	3.95	1.50
	1.58	2.23
	0.00 %	0.00 %
Operating Margin	4.04 %	4.99 %

Sector figures are the median of 98 listed Trading companies.

Peer Comparison

Name
ADANI ENTER ADANIENT	2,578.00	60.82	3,48,989.69	0.05	1,220.99	-64.24%	37,215.62	75.14%	13.30
CPPLUS CPPLUS	3,811.45	97.93	46,738.65	0.04	142.20	332.51%	1,402.42	89.51%	29.48
PREMIERENE PREMIERENE	866.00	23.61	39,312.20	0.12	471.92	53.32%	2,462.59	35.25%	33.72
AEGISLOG AEGISLOG	1,097.45	28.91	38,520.50	0.79	320.50	31.34%	2,213.34	-3.52%	19.76
REDINGTON REDINGTON	326.75	15.02	25,544.48	1.84	453.49	94.65%	34,922.47	34.57%	18.96
HONASA HONASA	442.20	57.91	14,416.79	0.68	90.45	118.87%	755.95	27.00%	20.87
SGMART SGMART	855.80	71.07	10,789.45	0.00	54.02	103.54%	1,561.84	-8.36%	10.43
Entero Healthcare Solutions Ltd. ENTERO	1,573.75	54.68	6,856.67	0.00	52.05	72.17%	1,940.50	38.23%	10.93

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1,034.18	1,097.04	1,300.69	1,359.00	1,339.06	1,403.82	1,570.95	1,706.52	1,909.93	1,940.50
Expenses	1,005.30	1,066.86	1,258.24	1,308.98	1,290.14	1,353.75	1,508.88	1,638.74	1,823.89	1,843.50
	28.88	30.17	42.45	50.01	48.91	50.07	62.07	67.77	86.04	96.99
	2.79%	2.75%	3.26%	3.68%	3.65%	3.57%	3.95%	3.97%	4.50%	5.00%
	9.15	13.44	11.28	7.50	7.29	5.83	4.79	-3.57	4.01	3.01
Interest	17.32	9.70	11.46	9.97	10.49	10.66	12.40	14.01	17.31	20.57
	7.14	6.61	7.49	8.10	8.49	8.87	9.83	9.80	14.79	12.31
	13.56	27.30	34.78	39.44	37.23	36.36	44.63	40.40	57.95	67.12
	-56.17%	24.80%	25.14%	25.33%	15.59%	16.86%	17.98%	16.14%	22.12%	22.45%
	20.97	20.08	23.62	25.44	25.69	27.80	31.60	27.63	28.01	38.16
	4.82	4.62	5.43	5.85	5.90	6.39	7.26	6.35	6.44	8.77

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	2,522.07	3,300.21	3,922.31	5,095.78	6,591.21
	2,522.07	3,300.21	3,922.31	5,095.78	6,591.21
EXPENDITURE :
Increase/Decrease in Stock	-30.03	-19.40	-57.46	-147.01	-4.01
Raw Material Consumed	2,342.47	3,051.26	3,627.81	4,756.49	5,914.84
Power & Fuel Cost	4.07	4.25	5.60	7.20	8.54
Employee Cost	114.81	128.14	151.15	199.04	245.50
Other Manufacturing Expenses	1.22	1.26	1.29	1.38	3.27
General and Administration Expenses	28.85	30.08	34.36	39.47	56.98
Selling and Distribution Expenses	26.01	29.68	36.28	52.39	74.97
Miscellaneous Expenses	10.23	10.93	11.44	15.27	25.18
	2,497.63	3,236.20	3,810.47	4,924.23	6,325.26
Operating Profit (Excl OI)	24.44	64.01	111.84	171.55	265.95
	4.48	5.51	14.41	39.51	19.24
	28.92	69.52	126.26	211.05	285.19
Interest	28.98	48.97	65.68	41.62	54.39
PBDT	-0.06	20.55	60.57	169.43	230.81
	19.75	24.24	25.02	30.69	43.29
Profit Before Taxation & Exceptional Items	-19.81	-3.69	35.56	138.74	187.51
Exceptional Income / Expenses					-8.18
	-19.81	-3.69	35.56	138.74	179.34
Provision for Tax	9.63	7.42	-4.24	31.31	33.50
	-29.44	-11.10	39.80	107.43	145.84
Extra items				0.00	0.00
Minority Interest	-0.48	-0.45	-0.69	-12.61	-30.80
Consolidated Net Profit	-29.92	-11.56	39.11	94.82	115.04
Profit Balance B/F	-31.85	-61.80	-72.70	-33.81	63.83
Appropriations	-61.77	-73.36	-33.59	61.01	178.87
	-77.71	-28.11	8.99	21.79	26.44
Adjusted EPS	-77.71	-28.11	8.99	21.79	26.44

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	622.84	667.73	43.49	43.51	43.51
Share Warrants & Outstandings			1.77	4.24	6.42
Total Reserves	-61.80	-72.70	1,592.79	1,676.40	1,638.68
Reserve excluding Revaluation Reserve	-61.80	-72.70	1,592.79	1,676.40	1,638.68
Revaluation reserve	0.00		0.00	0.00
	561.04	595.03	1,638.06	1,724.15	1,688.61
Minority Interest	2.18	2.63	3.33	46.21	63.94
Long-Term Borrowings	37.13
Secured Loans	37.13	31.07	45.54		99.76
Unsecured Loans					22.80
Deferred Tax Assets / Liabilities	1.07	-1.34	-19.00	-14.30	-53.99
Other Long Term Liabilities	57.69	49.97	48.97	77.50	115.95
Long Term Provisions	4.43	5.40	7.11	9.64	21.60
Total Non-Current Liabilities	100.31	85.10	82.62	72.84	206.12
Trade Payables	139.78	210.50	229.92	397.30	725.33
Other Current Liabilities	64.91	67.11	135.04	137.88	397.44
Short Term Borrowings	247.90	342.45	230.01	298.81	444.12
Short Term Provisions	9.19	3.90	6.98	11.02	20.68
Total Current Liabilities	461.78	623.96	601.95	845.02	1,587.57
Total Liabilities	1,125.31	1,306.72	2,325.95	2,688.21	3,546.24
Gross Block	311.22	338.72	383.27	686.47	1,129.14
Less: Accumulated Depreciation	49.25	70.99	93.93	127.19	171.11
	261.97	267.73	289.34	559.29	958.03
	0.59
Long Term Investment	0.00		0.00	0.00
Long Term Loans & Advances	11.82	14.42	20.20	47.16	72.38
Other Non Current Assets	0.00	1.40	5.44	5.80	4.94
Total Non-Current Assets	274.42	283.55	314.97	612.51	1,037.80
Currents Investments				57.56	129.89
Inventories	310.16	341.63	421.16	659.78	841.68
Sundry Debtors	374.60	514.88	615.40	830.36	1,212.44
Cash and Bank	105.40	106.84	893.18	260.42	161.79
Other Current Assets	24.35	23.17	40.52	66.29	89.06
Short Term Loans and Advances	36.38	36.65	40.71	201.31	68.28
Total Current Assets	850.88	1,023.17	2,010.98	2,075.71	2,503.13
Net Current Assets (Including Current Investments)	389.10	399.21	1,409.03	1,230.69	915.56
Total Assets	1,125.31	1,306.72	2,325.95	2,688.21	3,546.24
	0.01	0.30	0.35	4.01	5.51
Total Debt	285.03	374.32	275.55	298.81	566.68
	-150.52	-166.80	376.21	395.31	386.61
Adjusted Book Value	-150.52	-166.80	376.21	395.31	386.61

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	-19.81	-3.69	35.56	138.74	179.34
Adjustment	41.52	71.16	86.62	44.05	107.09
Changes In working Capital	-46.07	-100.36	-145.73	-221.52	-136.48
Cash Flow after changes in Working Capital	-24.36	-32.89	-23.55	-38.73	149.95
Cash Flow from Operating Activities	-35.27	-45.32	-36.61	-76.87	96.20
Cash Flow from Investing Activities	-161.73	-48.60	-705.12	219.80	-303.06
Cash Flow from Financing Activitie	211.19	72.76	862.94	-73.66	123.66
Net Cash Inflow / Outflow	14.19	-21.15	121.21	69.27	-83.20
Opening Cash & Cash Equivalents	32.31	46.51	25.36	147.65	229.28
Cash & Cash Equivalent on Amalgamation / Take over / Merger			1.08	12.36	0.80
Closing Cash & Cash Equivalent	46.51	25.36	147.65	229.28	146.88

Ratios

Valuation

54.68

3.95

22.05

0.96

28.78

398.17

Profitability

8.57

10.93

4.68

4.04

2.21

Leverage & Liquidity

0.34

1.58

4.30

Returns

0.00

2.11

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	52.44	52.44	52.44	52.42	52.42	52.42	52.42	52.42	52.40	52.40
	25.38	31.55	30.98	29.56	27.38	24.32	21.56	20.66	19.85	26.93
	22.18	16.01	16.59	18.02	20.19	23.26	26.02	26.93	27.75	20.67
	47.56	47.56	47.56	47.58	47.58	47.58	47.58	47.58	47.60	47.60
No. of Shareholders	66,400	36,767	33,172	33,159	33,338	36,334	40,333	39,084	39,709	40,919

Mutual Funds Invested(26)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 19 active funds hold 11.04% in Entero Healthcare Solutions Ltd., contributing to ₹822 Cr of holdings

Fund				As of
IN Invesco India Contra Fund - Growth - Direct PlanEquity - Contra Fund	203.77	1.06	11,92,406	Sep '26
HD HDFC Balanced Advantage Fund - Growth - Direct PlanHybrid - Balanced Advantage	202.16	0.20	11,83,000	Sep '26
BO Bank of India Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	70.00	2.26	4,09,613	Sep '26
IP ICICI Prudential Healthcare Fund - Growth - Direct PlanPharma & Health Care	50.92	0.74	2,97,995	Sep '26
ED Edelweiss Small Cap Fund - Growth - Direct PlanSmall cap Fund	48.27	0.69	2,82,466	Sep '26
BO Bank of India Small Cap Fund - Growth - Direct PlanSmall cap Fund	39.69	1.08	2,32,276	Sep '26
BO Bank of India Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	37.05	2.76	2,16,835	Sep '26
HD HDFC Pharma and Healthcare Fund - Growth - Direct PlanPharma & Health Care	35.37	1.01	2,07,000	Sep '26
MO Motilal Oswal Innovation Opportunities Fund - Growth - Direct PlanEquity - Thematic Fund - Other	27.20	3.18	1,59,188	Sep '26
IN Invesco India ELSS Tax Saver Fund - Growth - Direct PlanEquity - ELSS - Tax Saver Fund	26.22	1.01	1,53,434	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-22	Board Meeting	Quarterly Results
2026-07-28	AGM
2026-07-28	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

TradingTrading

Entero Healthcare Solutions Ltd. operates in the Trading sector under the Trading industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

8 members across the board and senior leadership

Sanu Kapoor

Vice President- Group General Counsel, Company Secretary & Compliance Officer

—

Sujesh Vasudevan

Chairman

₹23.25 L

Mar '26

Prabhat Agrawal

Managing Director & Chief Executive Officer

₹4.73 Cr

Mar '26

Prem Sethi

Whole Time Director & Chief Operating Officer

₹2.58 Cr

Mar '26

Rajesh Shashikant Dalal

Non Executive Independent Director

₹12.28 L

Mar '25

Sandhya Sharma

Non Executive Independent Director

₹18.75 L

Mar '26

Arun Sadhanandham

Nominee Director

—

Sumona Chakraborty

Nominee Director

—

ENTERO Latest News

News

3 of 3 articles

EQUITY28 Jul 2026 · 16:48

Entero Healthcare Solutions submits board meeting intimation

COMPANY26 May 2026 · 11:28

Entero Healthcare Solutions gets nod to acquire Vishal Surgicals, Vishal Surgicals & Medicals

The Board of Directors of the Company, at its meeting held on May 25, 2026, inter alia, considered and approved the same

EQUITY25 May 2026 · 21:00

Entero Healthcare reports Profit after tax of Rs 134.16 Mln, in the March 2026 quarter

Entero Healthcare Solutions Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(26)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

ENTERO Latest News

News